Favirpiravir yet to find favour with ICMR

However, the experts were not convinced and decided not to put it in the revised treatment protocol,” a person aware of the matter told ET on condition of anonymity.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2BTVwaO
via IFTTT